Our findings are reflective of the complex overlap of metabolic aberrations such as insulin resistance and weight-dependent, altered insulin metabolism associated with obesity and PCOS, which compound the risk of developing GDM. The gene discussed is INS; the disease is polycystic ovary syndrome.